Correlation Between Puma Biotechnology and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Mink Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Mink Therapeutics.
Diversification Opportunities for Puma Biotechnology and Mink Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Puma and Mink is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Mink Therapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.03 times more return on investment than Mink Therapeutics. However, Puma Biotechnology is 1.03 times more volatile than Mink Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 400.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (115.00) from holding Puma Biotechnology or give up 28.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Mink Therapeutics
Performance |
| Timeline |
| Puma Biotechnology |
| Mink Therapeutics |
Puma Biotechnology and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Mink Therapeutics
The main advantage of trading using opposite Puma Biotechnology and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Mink Therapeutics vs. Puma Biotechnology | Mink Therapeutics vs. Iovance Biotherapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals | Mink Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |